<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html
  PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html lang="en-us" xml:lang="en-us">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
<meta name="copyright" content="(C) Copyright 2005"/>
<meta name="DC.rights.owner" content="(C) Copyright 2005"/>
<meta name="DC.Type" content="topic"/>
<meta name="DC.Title" content="Medication Tapered Dose"/>
<meta name="abstract" content="[SubstanceAdministration: templateId 1.3.6.1.4.1.19376.1.5.3.1.4.8]"/>
<meta name="description" content="[SubstanceAdministration: templateId 1.3.6.1.4.1.19376.1.5.3.1.4.8]"/>
<meta name="DC.Coverage" content="SubstanceAdministration"/>
<meta name="DC.Relation" scheme="URI" content="../content/ClinicalStatementTemplates.html"/>
<meta name="DC.Format" content="XHTML"/>
<meta name="DC.Identifier" content="classId"/>
<meta name="DC.Language" content="en-us"/>
<link rel="stylesheet" type="text/css" href="../css/commonltr.css"/>
<title>Medication Tapered Dose</title>
</head>
<body id="classId"><a name="classId"><!-- --></a>
<div>
	<p><b>For Discussion and Demonstration Only</b> The Normative content for these specifications
	may be found on the HL7, IHE, and HITSP web sites.</p>
</div>

<h1 class="title topictitle1">Medication Tapered Dose</h1>



<div class="body"><p class="shortdesc">[SubstanceAdministration: templateId <tt class="ph tt">1.3.6.1.4.1.19376.1.5.3.1.4.8</tt>]</p>


<div class="section">
<p class="p">
    This template identifier is used to identify medication administration events that require special processing to handle
    tapered dosing. The parent template is 1.3.6.1.4.1.19376.1.5.3.1.4.7. A tapered dose is often used for certain
    medications where abrupt termination of the medication can have negative consequences. Tapered dosages may be done by
    adjusting the dose frequency, the dose amount, or both.
</p>

<p class="p">
    When merely the dose frequency is adjusted, (e.g., Prednisone 5mg b.i.d. for three days, then 5mg. daily for three
    days, and then 5mg every other day), then only one medication entry is needed, multiple frequency specifications
    recorded in &lt;effectiveTime&gt; elements. When the dose varies (eg. Prednisone 15mg daily for three days, then 10 mg
    daily for three days, the 5 mg daily for three days), subordinate medication entries should be created for each
    distinct dosage.
</p>

</div>



<ol class="ol">
<li class="li"><strong class="ph b">SHALL</strong> conform to <a class="xref" href="Medication.html" title="[SubstanceAdministration: templateId 2.16.840.1.113883.3.88.11.83.8]">Medication</a> template (templateId: <tt class="ph tt">2.16.840.1.113883.3.88.11.83.8</tt>)</li>

<li class="li"><strong class="ph b">SHALL</strong> satisfy: Subordinate Medication entries should be created for each distinct dosage.</li>

</ol>


<p class="p"> </p>

<p class="p"><strong class="ph b">Medication Tapered Dose example</strong></p>



<pre class="pre codeblock"/>

</div>

<div class="related-links">
<div class="familylinks">
<div class="parentlink"><strong>Parent topic:</strong> <a class="link" href="../content/ClinicalStatementTemplates.html">CLINICAL STATEMENT TEMPLATES</a></div>
</div>
</div>

</body>
</html>